Abstract | BACKGROUND: METHODS: RESULTS: Complete hemostasis was achieved in 28/30 patients (93.3%). The cumulative rebleeding rate after 1, 3 and 5 years was 13%, 19% and 19%, respectively. The 1-, 3-, and 5-year cumulative mortality rates were 31%, 54% and 59%, respectively. There was no complication related to infusion of vasopressin and sclerotherapy procedure. CONCLUSION:
|
Authors | Kuniyuki Kojima, Hiroo Imazu, Masahiko Matsumura, Yasuhiro Honda, Norie Umemoto, Hirohito Moriyasu, Toru Orihashi, Masanobu Uejima, Chie Morioka, Yoriaki Komeda, Masato Uemura, Hitoshi Yoshiji, Hiroshi Fukui |
Journal | Journal of gastroenterology and hepatology
(J Gastroenterol Hepatol)
Vol. 20
Issue 11
Pg. 1701-6
(Nov 2005)
ISSN: 0815-9319 [Print] Australia |
PMID | 16246189
(Publication Type: Journal Article)
|
Chemical References |
- Cyanoacrylates
- Hemostatics
- Oleic Acids
- Sclerosing Solutions
- Vasopressins
- Nitroglycerin
- ethanolamine oleate
|
Topics |
- Adult
- Aged
- Cyanoacrylates
(therapeutic use)
- Esophageal and Gastric Varices
(therapy)
- Feasibility Studies
- Female
- Gastric Fundus
- Gastrointestinal Hemorrhage
(mortality, therapy)
- Hemostasis, Endoscopic
- Hemostatics
(therapeutic use)
- Humans
- Male
- Middle Aged
- Nitroglycerin
(therapeutic use)
- Oleic Acids
(therapeutic use)
- Recurrence
- Sclerosing Solutions
(therapeutic use)
- Sclerotherapy
(adverse effects, methods)
- Survival Analysis
- Treatment Outcome
- Vasopressins
(therapeutic use)
|